Dr. Cynthia Boyd is the Mason F. Lord Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Boyd is the Director, Division of Geriatric Medicine and Gerontology. She holds a joint appointment in Health Policy and Management and Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Boyd is a faculty member at the Center for Transformative Geriatric Research, Johns Hopkins Center on Aging and Health and the Roger and Flo Lipitz Center to Advance Policy in Aging and Disability. A former Robert Wood Johnson Physician Faculty Scholar and a Beeson Scholar, Dr. Boyd is trained in internal medicine, geriatric medicine and epidemiology. Dr. Boyd’s career has focused on improving the health and well-being of older adults with multiple chronic conditions, with robust research and mentoring programs that have helped launch the careers of multiple junior faculty, fellows, medical students and other learners. Dr. Boyd is MPI of the NIA-funded US Deprescribing Research Network, has studied the inappropriate use of medications where harm may outweigh benefits, and has extensive experience leading and evaluating interventions to improve health for older adults. She earned her M.D. from the Duke University School of Medicine and her M.P.H. from the University of North Carolina at Chapel Hill. She completed her residency at Johns Hopkins Hospital and performed a fellowship in geriatric medicine at Johns Hopkins Bayview Medical Center. Dr. Boyd currently practices primary care and consultative geriatric care for older adults in Baltimore. Dr. Boyd has been recognized with several honors, including the American Geriatric Society’s Outstanding Scientific Achievement for Clinical Investigation Award, election to the American Society for Clinical Investigation, and Fellowship in the American College of Physicians and the American Geriatric Society. Her research has been funded by the NIH, AHRQ, PCORI, and foundations.

Prof. Dr. Petra A. Thürmann, MD, is Director of the Philipp Klee-Institute of Clinical Pharmacology, Helios University Clinic Wuppertal, Germany. Since 2021 she is Vice-President of the University of Witten/Herdecke. After studies of Medicine at the Johann Wolfgang Goethe-University in Frankfurt/Main she received a board certified specialist’s degree in Clinical Pharmacology in 1992 and PhD (Habilitation) in 1997. In 1997 appointment at the HELIOS University Clinic in Wuppertal and 1998 at the University of Witten/Herdecke. Petra Thürmann was member of the Executive Committee of IUPHAR between 2004 and 2018. She is member of the Drug Commission of the German Medical Association, served from to 2011 until 2023 at the Advisory Council on the Assessment of Developments in the Health Care System (German Ministry of Health) and belongs since 2023 to the Expert Advisory Council “Health and Resilience” of the Federal Government of Germany. Her research interest is focused on geriatric pharmacotherapy (e.g. PRISCUS list), drug therapy safety as well as gender medicine.

Naomi Gronich is a physician with an internal medicine specialty and a clinical pharmacology subspecialty, following a National Institute of Aging (NIH) fellowship, under the supervision of Dr. Darrell Abernethy. Naomi serves as an internist in the Department of Emergency Medicine, Lady Davis Carmel Medical Center; is in charge of Chronic Disease Registry and Pharmacogenetics in the Department of Community Medicine and Epidemiology of Clalit Health Services; and is an assistant Clinical Professor in the Medical Faculty of Technion- Israel Institute of Technology. Naomi studies effectiveness and adverse effects of medications, using real-world large-scale clinical data and pharmacoepidemiology methods, particularly in the elderly and in special populations such as pregnant women. Naomi serves in various committees including a national consulting committee for drug safety, American Society of Clinical Pharmacology and Therapeutics Committees, and the Geriatric Pharmacology Committee of IUPHAR.

Professor Shakib is Professor of Clinical Pharmacology at the University of Adelaide. His main research interest is in polypharmacy and new models of care for multimorbidity management.

Dr. Nashwa Masnoon is a Postdoctoral Research Fellow at the Laboratory of Ageing and Pharmacology, Kolling Institute, University of Sydney and Northern Sydney Local Health District and a Pharmacist at Royal North Shore Hospital. She completed her PhD in 2020 from the University of South Australia, which focused on identifying older adults at risk of harm from inappropriate polypharmacy. Her research areas are deprescribing, continuity of care during transitions and more broadly, the quality use of medicines.